No Data
No Data
Cantor Fitzgerald Maintains Merck & Co(MRK.US) With Buy Rating, Maintains Target Price $155
Cantor Fitzgerald analyst Louise Chen maintains $Merck & Co(MRK.US)$ with a buy rating, and maintains the target price at $155.According to TipRanks data, the analyst has a success rate of 39.7% and a
Cracking The Code: Understanding Analyst Reviews For Merck & Co
Merck & Co (NYSE:MRK) underwent analysis by 10 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.The following table summarizes their recent ratings, shedding li
Merck Prepares to Take on Pfizer After Pneumococcal Vaccine Approval -- Barrons.com
By Josh Nathan-Kazis The Food and Drug Administration approval of Merck's new pneumococcal vaccine tees up a new challenge to one of Pfizer's most important products. Pfizer currently dominates the
Competitor Analysis: Evaluating Merck & Co And Competitors In Pharmaceuticals Industry
In the ever-evolving and intensely competitive business landscape, conducting a thorough company analysis is of utmost importance for investors and industry followers. In this article, we will carry o
Merck's (MRK) 21-Valent Pneumococcal Jab Gets FDA Approval
Today's Morning Movers and Top Ratings: CHGG, KR, GME, STM and More
Gamestop shares declined by 3.05%, extending losses from the prior session, in the wake of CEO Ryan Cohen's announcement regarding the company's strategy to maintain a leaner network of retail stores.
No Data
182608752 : FDA always be great.